Meanwhile, Novartis seems to be leading the pack with TNO155, which has advanced to phase 2 testing as a monotherapy and is also in combination studies with Mirati's KRAS drug adagrasib.
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.
A new study published in PLOS Genetics has identified an extreme mutational hotspot within the genome of Pseudomonas ...
Acquired DNA mutations found in the SERPINA1 gene can protect liver cells from damage in patients with alpha-1 antitrypsin ...
A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...
In a study comparing the glioma tumors of firefighters and non-fighters, researchers found a mutational signature tied to exposure to haloalkanes, which are used in flame retardants, fire ...
The campus visit is one of the most important parts of your college selection process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback